Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2407

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies ; volume:18 ; number:1 ; day:27 ; month:4 ; year:2018 ; pages:1-7 ; date:12.2018
BMC cancer ; 18, Heft 1 (27.4.2018), 1-7, 12.2018

Creator: Vosoughi, Elham

Contributor: Lee, Jee Min
Miller, James R.
Nosrati, Mehdi
Minor, David R.
Abendroth, Roy
Lee, John W.
Andrews, Brian T.
Leng, Lewis Z.
Wu, Max
Leong, Stanley P.
Kashani-Sabet, Mohammed
Kim, Kevin B.
SpringerLink (Online service)

DOI: 10.1186/s12885-018-4374-x

URN: urn:nbn:de:101:1-2018070116095326043341

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:25 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Vosoughi, Elham
Lee, Jee Min
Miller, James R.
Nosrati, Mehdi
Minor, David R.
Abendroth, Roy
Lee, John W.
Andrews, Brian T.
Leng, Lewis Z.
Wu, Max
Leong, Stanley P.
Kashani-Sabet, Mohammed
Kim, Kevin B.
SpringerLink (Online service)

Other Objects (12)

Melanoma Brain Metastases: Local Therapies, Targeted Therapies, Immune Checkpoint Inhibitors and Their Combinations—Chances and Challenges

Melanoma: the role of surgery in the era of new therapies

Factors associated with hemorrhage of melanoma brain metastases after stereotactic radiosurgery in the era of targeted/immune checkpoint inhibitor therapies

Combination of immune-checkpoint inhibitors and targeted therapies for melanoma therapy: The more, the better?

Primary Resistance to Immune Checkpoint Inhibitors in Patients with Metastatic Melanoma : Prognosis, Subsequent Therapies and Survival

Targeted Therapies for Melanoma Brain Metastases

Myopericytoma mimicking subcutaneous melanoma metastasis

Surgery in the combination therapies era

Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors

Novel combination therapies for BRAF-mutant melanoma

Checkpoint inhibitor induced hepatitis and the relation with liver metastasis and outcome in advanced melanoma patients

Hochschulschrift

Platelet surface receptors and melanoma metastasis

Melanoma Brain Metastases: Local Therapies, Targeted Therapies, Immune Checkpoint Inhibitors and Their Combinations—Chances and Challenges

Melanoma: the role of surgery in the era of new therapies

Factors associated with hemorrhage of melanoma brain metastases after stereotactic radiosurgery in the era of targeted/immune checkpoint inhibitor therapies

Combination of immune-checkpoint inhibitors and targeted therapies for melanoma therapy: The more, the better?

Primary Resistance to Immune Checkpoint Inhibitors in Patients with Metastatic Melanoma : Prognosis, Subsequent Therapies and Survival

Targeted Therapies for Melanoma Brain Metastases

Myopericytoma mimicking subcutaneous melanoma metastasis

Surgery in the combination therapies era

Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors

Novel combination therapies for BRAF-mutant melanoma

Checkpoint inhibitor induced hepatitis and the relation with liver metastasis and outcome in advanced melanoma patients

Hochschulschrift

Platelet surface receptors and melanoma metastasis

Melanoma Brain Metastases: Local Therapies, Targeted Therapies, Immune Checkpoint Inhibitors and Their Combinations—Chances and Challenges

Melanoma: the role of surgery in the era of new therapies

Factors associated with hemorrhage of melanoma brain metastases after stereotactic radiosurgery in the era of targeted/immune checkpoint inhibitor therapies

Combination of immune-checkpoint inhibitors and targeted therapies for melanoma therapy: The more, the better?

Primary Resistance to Immune Checkpoint Inhibitors in Patients with Metastatic Melanoma : Prognosis, Subsequent Therapies and Survival

Targeted Therapies for Melanoma Brain Metastases

Myopericytoma mimicking subcutaneous melanoma metastasis

Surgery in the combination therapies era

Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors

Novel combination therapies for BRAF-mutant melanoma

Checkpoint inhibitor induced hepatitis and the relation with liver metastasis and outcome in advanced melanoma patients

Hochschulschrift

Platelet surface receptors and melanoma metastasis

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Melanoma Brain Metastases: Local Therapies, Targeted Therapies, Immune Checkpoint Inhibitors and Their Combinations—Chances and Challenges

Melanoma: the role of surgery in the era of new therapies

Factors associated with hemorrhage of melanoma brain metastases after stereotactic radiosurgery in the era of targeted/immune checkpoint inhibitor therapies

Combination of immune-checkpoint inhibitors and targeted therapies for melanoma therapy: The more, the better?

Primary Resistance to Immune Checkpoint Inhibitors in Patients with Metastatic Melanoma : Prognosis, Subsequent Therapies and Survival

Targeted Therapies for Melanoma Brain Metastases

Myopericytoma mimicking subcutaneous melanoma metastasis

Surgery in the combination therapies era

Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors

Novel combination therapies for BRAF-mutant melanoma

Checkpoint inhibitor induced hepatitis and the relation with liver metastasis and outcome in advanced melanoma patients

Platelet surface receptors and melanoma metastasis

Melanoma Brain Metastases: Local Therapies, Targeted Therapies, Immune Checkpoint Inhibitors and Their Combinations—Chances and Challenges

Melanoma: the role of surgery in the era of new therapies

Factors associated with hemorrhage of melanoma brain metastases after stereotactic radiosurgery in the era of targeted/immune checkpoint inhibitor therapies

Combination of immune-checkpoint inhibitors and targeted therapies for melanoma therapy: The more, the better?

Primary Resistance to Immune Checkpoint Inhibitors in Patients with Metastatic Melanoma : Prognosis, Subsequent Therapies and Survival

Targeted Therapies for Melanoma Brain Metastases

Myopericytoma mimicking subcutaneous melanoma metastasis

Surgery in the combination therapies era

Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors

Novel combination therapies for BRAF-mutant melanoma

Checkpoint inhibitor induced hepatitis and the relation with liver metastasis and outcome in advanced melanoma patients

Platelet surface receptors and melanoma metastasis

Melanoma Brain Metastases: Local Therapies, Targeted Therapies, Immune Checkpoint Inhibitors and Their Combinations—Chances and Challenges

Melanoma: the role of surgery in the era of new therapies

Factors associated with hemorrhage of melanoma brain metastases after stereotactic radiosurgery in the era of targeted/immune checkpoint inhibitor therapies

Combination of immune-checkpoint inhibitors and targeted therapies for melanoma therapy: The more, the better?

Primary Resistance to Immune Checkpoint Inhibitors in Patients with Metastatic Melanoma : Prognosis, Subsequent Therapies and Survival

Targeted Therapies for Melanoma Brain Metastases

Myopericytoma mimicking subcutaneous melanoma metastasis

Surgery in the combination therapies era

Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors

Novel combination therapies for BRAF-mutant melanoma

Checkpoint inhibitor induced hepatitis and the relation with liver metastasis and outcome in advanced melanoma patients

Platelet surface receptors and melanoma metastasis

Related objects

Reset password